{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:59:57Z","timestamp":1791874797754,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,1,13]],"date-time":"2013-01-13T00:00:00Z","timestamp":1358035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00520-012-1697-z","type":"journal-article","created":{"date-parts":[[2013,1,12]],"date-time":"2013-01-12T02:59:41Z","timestamp":1357959581000},"page":"1569-1577","source":"Crossref","is-referenced-by-count":137,"title":["Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients"],"prefix":"10.1007","volume":"21","author":[{"given":"Ola","family":"Wallengren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Lundholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvar","family":"Bosaeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,13]]},"reference":[{"issue":"5","key":"1697_CR1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489\u2013495. doi: 10.1016\/S1470-2045(10)70218-7","journal-title":"Lancet Oncol"},{"key":"1697_CR2","doi-asserted-by":"crossref","unstructured":"Blum D, Omlin A, Baracos VE, Solheim TS, Tan BH, Stone P, Kaasa S, Fearon K, Strasser F (2011) Cancer cachexia: a systematic literature review of items and domains associated with involuntary weight loss in cancer. Crit Rev Oncol Hematol. doi: 10.1016\/j.critrevonc.2010.10.004","DOI":"10.1016\/j.critrevonc.2010.10.004"},{"issue":"2","key":"1697_CR3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOG.0b013e3283347e77","volume":"26","author":"MJ Tisdale","year":"2010","unstructured":"Tisdale MJ (2010) Cancer cachexia. Curr Opin Gastroenterol 26(2):146\u2013151. doi: 10.1097\/MOG.0b013e3283347e77","journal-title":"Curr Opin Gastroenterol"},{"issue":"4","key":"1697_CR4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0148607108325076","volume":"33","author":"F Bozzetti","year":"2009","unstructured":"Bozzetti F, Mariani L (2009) Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. J Parenter Enter Nutr 33(4):361\u2013367. doi: 10.1177\/0148607108325076","journal-title":"J Parenter Enter Nutr"},{"issue":"6","key":"1697_CR5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","volume":"27","author":"WJ Evans","year":"2008","unstructured":"Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27(6):793\u2013799. doi: 10.1016\/j.clnu.2008.06.013","journal-title":"Clin Nutr"},{"issue":"6","key":"1697_CR6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","volume":"83","author":"KC Fearon","year":"2006","unstructured":"Fearon KC, Voss AC, Hustead DS (2006) Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83(6):1345\u20131350","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"1697_CR7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MCO.0b013e328352a895","volume":"15","author":"N Macdonald","year":"2012","unstructured":"Macdonald N (2012) Terminology in cancer cachexia: importance and status. Curr Opin Clin Nutr Metab Care 15(3):220\u2013225. doi: 10.1097\/MCO.0b013e328352a895","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"5","key":"1697_CR8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djr556","volume":"104","author":"C Baldwin","year":"2012","unstructured":"Baldwin C, Spiro A, Ahern R, Emery PW (2012) Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta-analysis. J Natl Cancer Inst 104(5):371\u2013385. doi: 10.1093\/jnci\/djr556","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1697_CR9","first-page":"5","volume":"28","author":"M Elia","year":"2006","unstructured":"Elia M, Bokhorst-de V, van der Schueren MA, Garvey J, Goedhart A, Lundholm K, Nitenberg G, Stratton RJ (2006) Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 28(1):5\u201323","journal-title":"Int J Oncol"},{"issue":"9","key":"1697_CR10","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/cncr.20160","volume":"100","author":"K Lundholm","year":"2004","unstructured":"Lundholm K, Daneryd P, Bosaeus I, Korner U, Lindholm E (2004) Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. Cancer 100(9):1967\u20131977","journal-title":"Cancer"},{"issue":"2","key":"1697_CR11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","volume":"15","author":"G Mantovani","year":"2010","unstructured":"Mantovani G, Maccio A, Madeddu C, Serpe R, Massa E, Dessi M, Panzone F, Contu P (2010) Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. Oncologist 15(2):200\u2013211. doi: 10.1634\/theoncologist.2009-0153","journal-title":"Oncologist"},{"issue":"1","key":"1697_CR12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00109-009-0547-z","volume":"88","author":"G Mantovani","year":"2010","unstructured":"Mantovani G, Maccio A, Madeddu C, Serpe R, Antoni G, Massa E, Dessi M, Panzone F (2010) Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia. J Mol Med (Berl) 88(1):85\u201392. doi: 10.1007\/s00109-009-0547-z","journal-title":"J Mol Med (Berl)"},{"issue":"8","key":"1697_CR13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ejca.2008.02.033","volume":"44","author":"KC Fearon","year":"2008","unstructured":"Fearon KC (2008) Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer 44(8):1124\u20131132. doi: 10.1016\/j.ejca.2008.02.033","journal-title":"Eur J Cancer"},{"issue":"21","key":"1697_CR14","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","volume":"24","author":"KC Fearon","year":"2006","unstructured":"Fearon KC, Barber MD, Moses AG, Ahmedzai SH, Taylor GS, Tisdale MJ, Murray GD (2006) Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 24(21):3401\u20133407. doi: 10.1200\/JCO.2005.04.5724","journal-title":"J Clin Oncol"},{"key":"1697_CR15","first-page":"693458","volume":"2009","author":"KM Fox","year":"2009","unstructured":"Fox KM, Brooks JM, Gandra SR, Markus R, Chiou CF (2009) Estimation of cachexia among cancer patients based on four definitions. J Oncol 2009:693458. doi: 10.1155\/2009\/693458","journal-title":"J Oncol"},{"key":"1697_CR16","doi-asserted-by":"crossref","unstructured":"Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, Prado CM, Birdsell L, Falkmer U (2012) Nutritional status, cachexia and survival in patients with advanced colorectal carcinoma. Different assessment criteria for nutritional status provide unequal results. Clin Nutr. doi: 10.1016\/j.clnu.2012.05.009","DOI":"10.1016\/j.clnu.2012.05.009"},{"issue":"3","key":"1697_CR17","first-page":"505","volume":"24","author":"K Lundholm","year":"2004","unstructured":"Lundholm K, Daneryd P, Korner U, Hyltander A, Bosaeus I (2004) Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol 24(3):505\u2013512","journal-title":"Int J Oncol"},{"issue":"23","key":"1697_CR18","first-page":"5374","volume":"58","author":"P Daneryd","year":"1998","unstructured":"Daneryd P, Svanberg E, Korner U, Lindholm E, Sandstrom R, Brevinge H, Pettersson C, Bosaeus I, Lundholm K (1998) Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study. Cancer Res 58(23):5374\u20135379","journal-title":"Cancer Res"},{"issue":"20","key":"1697_CR19","doi-asserted-by":"crossref","first-page":"6855","DOI":"10.1158\/1078-0432.CCR-04-0373","volume":"10","author":"E Lindholm","year":"2004","unstructured":"Lindholm E, Daneryd P, Korner U, Hyltander A, Fouladiun M, Lundholm K (2004) Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients. Clin Cancer Res 10(20):6855\u20136864. doi: 10.1158\/1078-0432.CCR-04-0373","journal-title":"Clin Cancer Res"},{"issue":"9","key":"1697_CR20","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1158\/1078-0432.CCR-06-2720","volume":"13","author":"K Lundholm","year":"2007","unstructured":"Lundholm K, Korner U, Gunnebo L, Sixt-Ammilon P, Fouladiun M, Daneryd P, Bosaeus I (2007) Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning. Clin Cancer Res 13(9):2699\u20132706. doi: 10.1158\/1078-0432.CCR-06-2720","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1697_CR21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0261-5614(82)90015-2","volume":"1","author":"T Symreng","year":"1982","unstructured":"Symreng T (1982) Arm anthropometry in a large reference population and in surgical patients. Clin Nutr 1(3):211\u2013219","journal-title":"Clin Nutr"},{"issue":"1","key":"1697_CR22","first-page":"45","volume":"201","author":"H Persson","year":"1985","unstructured":"Persson H, Bennegard K, Lundberg PA, Svaninger G, Lundholm K (1985) Thyroid hormones in conditions of chronic malnutrition. A study with special reference to cancer cachexia. Ann Surg 201(1):45\u201352","journal-title":"Ann Surg"},{"key":"1697_CR23","first-page":"79","volume":"39","author":"L H\u00e5glin","year":"1995","unstructured":"H\u00e5glin L, Hagman U, Nilsson M (1995) Evaluation of the meal model \"Matmallen\". A means of estimating consumed amounts of food. Scandinavian Journal of Nutrition 39:79\u201383","journal-title":"Scandinavian Journal of Nutrition"},{"issue":"5","key":"1697_CR24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376","journal-title":"J Natl Cancer Inst"},{"key":"1697_CR25","unstructured":"Scott NW FP, Aaronson NK, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MAG on behalf of the EORTC Quality of Life Group (2008) EORTC QLQ-C30 reference values. http:\/\/groups.eortc.be\/qol\/sites\/default\/files\/img\/newsletter\/reference_values_manual2008.pdf"},{"issue":"1","key":"1697_CR26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139\u2013144","journal-title":"J Clin Oncol"},{"issue":"9","key":"1697_CR27","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","volume":"10","author":"C Quinten","year":"2009","unstructured":"Quinten C, Coens C, Mauer M, Comte S, Sprangers MA, Cleeland C, Osoba D, Bjordal K, Bottomley A (2009) Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. Lancet Oncol 10(9):865\u2013871. doi: 10.1016\/S1470-2045(09)70200-1","journal-title":"Lancet Oncol"},{"key":"1697_CR28","doi-asserted-by":"crossref","unstructured":"Trajkovic-Vidakovic M, de Graeff A, Voest EE, Teunissen SCCM (2012) Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. Critical Reviews in Oncology\/Hematology (0)","DOI":"10.1016\/j.critrevonc.2012.02.011"},{"issue":"3","key":"1697_CR29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clnu.2007.01.005","volume":"26","author":"MM Marin Caro","year":"2007","unstructured":"Marin Caro MM, Laviano A, Pichard C (2007) Nutritional intervention and quality of life in adult oncology patients. Clin Nutr 26(3):289\u2013301","journal-title":"Clin Nutr"},{"issue":"7","key":"1697_CR30","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1017\/S0007114508207178","volume":"101","author":"C Wanden-Berghe","year":"2009","unstructured":"Wanden-Berghe C, Sanz-Valero J, Escriba-Aguir V, Castello-Botia I, Guardiola-Wanden-Berghe R (2009) Evaluation of quality of life related to nutritional status. Br J Nutr 101(7):950\u2013960. doi: 10.1017\/S0007114508207178","journal-title":"Br J Nutr"},{"key":"1697_CR31","doi-asserted-by":"crossref","unstructured":"Wallengren O, Bosaeus I, Lundholm K (2012) Dietary energy density, inflammation and energy balance in palliative care cancer patients. Clin Nutr. doi: 10.1016\/j.clnu.2012.05.023","DOI":"10.1016\/j.clnu.2012.05.023"},{"issue":"3","key":"1697_CR32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1615\/CritRevOncog.v17.i3.70","volume":"17","author":"A Vigano","year":"2012","unstructured":"Vigano A, Del Fabbro E, Bruera E, Borod M (2012) The cachexia clinic: from staging to managing nutritional and functional problems in advanced cancer patients. Crit Rev Oncog 17(3):293\u2013304","journal-title":"Crit Rev Oncog"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1697-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-012-1697-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1697-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T02:46:13Z","timestamp":1562553973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-012-1697-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,13]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1007\/s00520-012-1697-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,13]]}}}